Correlation Between GlaxoSmithKline PLC and Royal Helium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Royal Helium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Royal Helium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Royal Helium, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Royal Helium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Royal Helium. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Royal Helium.

Diversification Opportunities for GlaxoSmithKline PLC and Royal Helium

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between GlaxoSmithKline and Royal is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Royal Helium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royal Helium and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Royal Helium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royal Helium has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Royal Helium go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Royal Helium

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.2 times more return on investment than Royal Helium. However, GlaxoSmithKline PLC ADR is 5.09 times less risky than Royal Helium. It trades about 0.0 of its potential returns per unit of risk. Royal Helium is currently generating about -0.07 per unit of risk. If you would invest  3,462  in GlaxoSmithKline PLC ADR on August 26, 2024 and sell it today you would lose (66.00) from holding GlaxoSmithKline PLC ADR or give up 1.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.6%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Royal Helium

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Royal Helium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Royal Helium has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

GlaxoSmithKline PLC and Royal Helium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Royal Helium

The main advantage of trading using opposite GlaxoSmithKline PLC and Royal Helium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Royal Helium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royal Helium will offset losses from the drop in Royal Helium's long position.
The idea behind GlaxoSmithKline PLC ADR and Royal Helium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation